Dual therapy with an angiotensin receptor blocker and a JAK1/2 inhibitor attenuates dialysate-induced angiogenesis and preserves peritoneal membrane structure and function in an experimental CKD rat model
Related Posts
Jang J, Nold T, Marshalek JP, Matthiesen J, Tomassetti S. Retrospective study of antimicrobial prophylaxis and infections in patients with acute myeloid leukemia. J Oncol[...]
Ghotbi E, Hathaway QA, Jannatdoust P, Hadidchi R, Bancks MP, Bluemke DA, Budoff M, Post W, Hoffman EA, Smith BM, Lima JAC, Barr RG, Demehri[...]
Andishmand A, Soltani MH, Mohammadi H, Namayandeh SM, Peigan P, Budoff M, Azimizadeh M, Andishmand M, Andishmand M. Predictors of bleeding-related in-hospital complications after coronary[...]